FOIAengine: Neuralink’s High Profile Makes It a Target It was a Musk Moment unlike any other: Two weeks ago, the first human participant in Neuralink’s brain-implant trials took the stage to show how he could play chess by imagining where he wanted the pieces to go. ...
FOIAengine: Conservative Activists, Law Firms, Non-Profits Signal Competing Agendas A review of the most recent Freedom of Information Act requests made to the Food and Drug Administration illustrates how political organizations, law firms, news media, and financial...
FOIAengine Spotlights a Non-Profit Newsroom and Another Problem for the FDA The Food and Drug Administration was already under fire from Congress and others after hundreds of toddlers in 44 states were poisoned last year by lead-tainted pouches of apple puree and...
FOIAengine Previews an April Fool's Day Courtrooom Grudge Match This week’s story is about two litigation magnets. One is a household name whose lawsuit against OpenAI dominated the news a few days ago. That would be Elon Musk. The other – Aaron Greenspan – is, at...
FOIAengine Breaks Down the Action Financial firms are continuing to monitor many of the pharmaceutical manufacturers we’ve reported on in recent months, including Krystal Biotech, Apellis Pharmaceuticals, Establishment Labs, Catalent and Astellas. That’s according to...
FOIAengine: Who's Asking What, and Why? Days after the Federal Trade Commission launched an investigation of the five biggest players in artificial intelligence, Lina Khan was on a charm offensive aimed at winning the confidence of her biggest enemies on Wall Street. ...
